← Back to headlines
Bayer Receives FDA Priority Review for Asundexian
Bayer has been granted FDA priority review for its drug asundexian, intended for use in stroke and TIA patients.
19 May, 06:41 — 19 May, 06:41
Sources
Showing 1 of 1 sources
Related Stories
Amazon's First Customer Receipt Goes Viral, Bezos and Musk React
just now
Manila Water's Upper Wawa Dam Recognized as Water Project of the Year
just now
22-year-old Scams 68-year-old Woman Out of Over 150,000 PLN in Investment Fraud
14m ago
Ubisoft Co-Founder Claude Guillemot Dies Piloting Plane in French Crash
23m ago